Ads
related to: gambro dialysis
Search results
Results From The WOW.Com Content Network
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [ clarify ] , and other extracorporeal therapies for chronic and acute patients.
In addition, Baxter will build upon its core portfolio and pipeline of investigational home hemodialysis (HD) and automated PD systems by adding Gambro's dialyzers, devices and dialysis solutions ...
Baxter International (NYS: BAX) announced today that it has agreed to buy privately held dialysis systems maker Gambro AB for approximately $4 billion in total consideration. In a statement ...
In 1981, Gambro "diversified into the heart-lung product area and built up a special network of suppliers", [10] developing other technologies for treating blood outside the body (extracorporeally), for example in connection with heart surgery, and blood component technology, which separates blood into different components and then uses some of ...
Gambro opened its first dialysis clinic in Lund in 1991. The clinic activities expanded under the name Gambro Healthcare and by 2005 the company managed 150 dialysis clinics worldwide. Gambro Healthcare was divested from Gambro in 2007 and taken over by Bridgepoint Capital, a major private healthcare investor in Europe, and the company ...
A liver support system or diachysis is a type of therapeutic device to assist in performing the functions of the liver. Such systems focus either on removing the accumulating toxins (liver dialysis), or providing additional replacement of the metabolic functions of the liver through the inclusion of hepatocytes to the device (bioartificial liver device).
Ad
related to: gambro dialysis